Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Locatelli F et al. – Valsartan has been studied extensively and is widely used for the management of hypertension. Data from clinical studies involving valsartan and other ARBs and ACE inhibitors provide evidence of an additional renal protective effect. This renal protection apparently arises from hemodynamic, endothelial, and anti–inflammatory actions.

   

Related Articles

Protection from sepsis-induced acute renal failure by adenoviral-mediated gene transfer of beta2-adrenoceptor
Nephrology Dialysis Transplantation, 11/05/09    Relevance Score: 68%

Renal Protection by Ischemic Preconditioning Is Associated with p50/p50 Homodimers
American Journal of Nephrology, 11/04/09    Relevance Score: 67%

Genetic Polymorphisms of Immunoregulatory Proteins in Acute Renal Allograft Rejection
Transplantation Proceedings, 11/10/09    Relevance Score: 66%

Low-dose indomethacin after ischemic acute kidney injury prevents down regulation of Oat1/3 and improves renal outcome
American Journal of Physiology: Renal Physiology, 10/01/09    Relevance Score: 66%

Predictors of Residual Renal Function Loss in Peritoneal Dialysis: Is Previous Renal Transplantation a Risk Factor
Advances in Peritoneal Dialysis, 10/21/09    Relevance Score: 65%

Today in Nephrology...keeping you current

Tracing the Origin of Glomerular Extracapillary Lesions from Parietal Epithelial Cells
Journal of the American Society of Nephrology, 11/25/09

The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/25/09

25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
Journal of the American Society of Nephrology, 11/25/09

Today in Hypertension...keeping you current

Managing Peripheral Edema in Patients With Arterial Hypertension
American Journal of Therapeutics, 11/25/09

Health Care Services Provided During Physician Office Visits for Hypertension: Differences by Specialty
The Journal of Clinical Hypertension, 11/25/09

Efficacy of an Olmesartan Medoxomil–Based Treatment Algorithm in Patients Stratified by Age, Race, or Sex
The Journal of Clinical Hypertension, 11/25/09

Today in Pharmacology/kinetics...keeping you current

Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrology Dialysis Transplantation, 11/25/09

Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
Hypertension, 11/24/09

Bilateral renal inflammatory pseudotumour effectively treated with corticosteroid
Clinical and Experimental Nephrology, 11/24/09

Today in Nephrology...keeping you current

The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/25/09

Tracing the Origin of Glomerular Extracapillary Lesions from Parietal Epithelial Cells
Journal of the American Society of Nephrology, 11/25/09

25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
Journal of the American Society of Nephrology, 11/25/09

Today in Other Drugs...keeping you current

Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
Current Medical Research and Opinion, 11/25/09

Anti-relapse medications: Preclinical models for drug addiction treatment
Pharmacology & Therapeutics, 11/25/09

Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address